Ilyang Pharmaceutical Co Ltd
KRX:007570
Ilyang Pharmaceutical Co Ltd
Pre-Tax Income
Ilyang Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Ilyang Pharmaceutical Co Ltd
KRX:007570
|
Pre-Tax Income
₩1.5B
|
CAGR 3-Years
-62%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-12%
|
Yuhan Corp
KRX:000100
|
Pre-Tax Income
₩113.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Pre-Tax Income
-₩43.9B
|
CAGR 3-Years
43%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Pre-Tax Income
₩194B
|
CAGR 3-Years
106%
|
CAGR 5-Years
31%
|
CAGR 10-Years
13%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Pre-Tax Income
-₩3.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Pre-Tax Income
₩20.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
See Also
What is Ilyang Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
1.5B
KRW
Based on the financial report for Mar 31, 2024, Ilyang Pharmaceutical Co Ltd's Pre-Tax Income amounts to 1.5B KRW.
What is Ilyang Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-12%
Over the last year, the Pre-Tax Income growth was -96%. The average annual Pre-Tax Income growth rates for Ilyang Pharmaceutical Co Ltd have been -62% over the past three years , -30% over the past five years , and -12% over the past ten years .